Hu CS - Search Results

1

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Wang S, et al. Among authors: hu cs. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1399-407. doi: 10.1016/j.ijrobp.2006.07.1337. Epub 2006 Sep 25. Int J Radiat Oncol Biol Phys. 2006. PMID: 16997503

2

Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.

Hu C, Chang EL, Hassenbusch SJ 3rd, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z. Hu C, et al. Cancer. 2006 May 1;106(9):1998-2004. doi: 10.1002/cncr.21818. Cancer. 2006. PMID: 16572401 Free article.

3

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Wei X, et al. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):100-7. doi: 10.1016/j.ijrobp.2006.04.022. Epub 2006 Jul 12. Int J Radiat Oncol Biol Phys. 2006. PMID: 16839700

4

The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y. Kong L, et al. Cancer. 2006 Sep 15;107(6):1287-93. doi: 10.1002/cncr.22119. Cancer. 2006. PMID: 16909425 Free article.

5

Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Yom SS, et al. Among authors: hu cs. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):94-102. doi: 10.1016/j.ijrobp.2006.12.031. Epub 2007 Feb 22. Int J Radiat Oncol Biol Phys. 2007. PMID: 17321067

6

Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy.

Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Wang S, et al. J Thorac Oncol. 2008 Mar;3(3):277-82. doi: 10.1097/JTO.0b013e3181653ca6. J Thorac Oncol. 2008. PMID: 18317071 Free article.

7

Patterns of retropharyngeal node metastasis in nasopharyngeal carcinoma.

Wang XS, Hu CS, Ying HM, Zhou ZR, Ding JH, Feng Y. Wang XS, et al. Among authors: hu cs. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):194-201. doi: 10.1016/j.ijrobp.2008.03.067. Epub 2008 Jun 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 18538502

8

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma.

He XY, Hu CS, Ying HM, Wu YR, Zhu GP, Liu TF. He XY, et al. Among authors: hu cs. Eur Arch Otorhinolaryngol. 2010 May;267(5):773-8. doi: 10.1007/s00405-009-1112-7. Epub 2009 Oct 10. Eur Arch Otorhinolaryngol. 2010. PMID: 19820959

9

Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?

Gao Y, Zhu G, Lu J, Ying H, Kong L, Wu Y, Hu C. Gao Y, et al. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1397-402. doi: 10.1016/j.ijrobp.2009.06.062. Epub 2010 Jan 13. Int J Radiat Oncol Biol Phys. 2010. PMID: 20044215

10

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.

Kong L, Zhang YW, Hu CS, Guo Y. Kong L, et al. Among authors: hu cs. Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. Chin J Cancer. 2010. PMID: 20426907 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters